Literature DB >> 9701649

Xanthine oxidoreductase gene expression and enzyme activity in developing human tissues.

M Saksela1, R Lapatto, K O Raivio.   

Abstract

Xanthine oxidoreductase (XOR) has been implicated in tissue injury following ischemia-reperfusion because of its ability to generate reactive oxygen species under these conditions. In order to elucidate its role in various organs, we quantified the levels of XOR mRNA expression and activity in developing human tissues. XOR gene expression was highest in the intestine and in the liver, which also showed the highest enzyme activities. By a sensitive RNA-PCR assay, low levels of the transcript were detected in the kidney, lung, cardiac muscle, and brain of all subjects studied. XOR activities followed the mRNA distribution, being low or undetectable in tissues other than the liver and the intestine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9701649     DOI: 10.1159/000014034

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  5 in total

1.  Interaction between eye pigment genes and tau-induced neurodegeneration in Drosophila melanogaster.

Authors:  Surendra S Ambegaokar; George R Jackson
Journal:  Genetics       Date:  2010-06-30       Impact factor: 4.562

2.  Possible role of insulin resistance in activation of plasma xanthine oxidoreductase in health check-up examinees.

Authors:  Masafumi Kurajoh; Shinya Fukumoto; Seigo Akari; Takayo Murase; Takashi Nakamura; Kanae Takahashi; Hisako Yoshida; Shinya Nakatani; Akihiro Tsuda; Tomoaki Morioka; Katsuhito Mori; Yasuo Imanishi; Kazuto Hirata; Masanori Emoto
Journal:  Sci Rep       Date:  2022-06-18       Impact factor: 4.996

Review 3.  Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology.

Authors:  Enrico Garattini; Ralf Mendel; Maria João Romão; Richard Wright; Mineko Terao
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

4.  Xanthine Oxidoreductase Inhibitor Use Associated With Reduced Risk of Sarcopenia and Severe Sarcopenia in Patients Undergoing Hemodialysis.

Authors:  Masafumi Kurajoh; Katsuhito Mori; Mizuki Miyabe; Shota Matsufuji; Akane Kizu; Yoshihiro Tsujimoto; Masanori Emoto
Journal:  Front Med (Lausanne)       Date:  2022-02-07

Review 5.  The Good, the Bad and the New about Uric Acid in Cancer.

Authors:  Simone Allegrini; Mercedes Garcia-Gil; Rossana Pesi; Marcella Camici; Maria Grazia Tozzi
Journal:  Cancers (Basel)       Date:  2022-10-10       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.